Results 211 to 220 of about 360,017 (261)

Association of Genetic Variants in <i>PNPLA3</i>, <i>MBOAT7</i>, and <i>MARC1</i> with Metabolic and Hematological Immune-Inflammation Indices in Adolescent Females with and Without MASLD: A Multilevel Risk-Allele Burden Analysis. [PDF]

Int J Mol Sci
Jurkovic Mlakar S, Klisic A, Marc J, Ostanek B.   +3 more
europepmc   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Editorial: Re-visiting risk factors for cardiometabolic diseases: towards a new epidemiological frontier. [PDF]

Front Public Health
Sethi Y, Padda I, Parmar MS, Tian L, Johal G.   +4 more
europepmc   +1 more source

Metabolic-inflammatory burden predicts mortality in heart failure across population and ICU cohorts. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Zhang K, Sun F.
europepmc   +1 more source

Imaging-defined subclinical atherosclerosis in subclinical hypothyroidism: Prevalence, associated factors, and preventive implications. [PDF]

Am Heart J Plus
Albulushi A, Hasan MS, Alazawi RS, Al Sarmi M, Al-Mandhari H, AlShaharli A, Hasan AS, Al-Helli Y, Allo A, Abdelazim E, Taha T, Sena A, Alhazmi AM, Alfehaid LS.   +13 more
europepmc   +1 more source

Global Co-Occurrence Patterns of Ischemic Heart Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease: Spatial Clusters, Risk Factors, and Quality-of-Care Index. [PDF]

J Am Heart Assoc
Wang W, Jiang WD, Wang L, Sun JH, Li ZJ, Wu ZZ, Qin AQ, Qiu S, Liu W.   +8 more
europepmc   +1 more source

Metabolic Syndrome Is Associated with Greater Symptom Burden and Comorbidity in Chronic Obstructive Pulmonary Disease: A Secondary Analysis of the Serbian COPD Registry. [PDF]

Med Sci (Basel)
Vukoja M, Bojović M, Kopitovic I, Dimic Janjic S, Novkovic L, Cekerevac I, Stankovic I, Bozanic B, Hromis S, Zvezdin B, Lazic Z, Cupurdija V.   +11 more
europepmc   +1 more source

Global burden of metabolic diseases, 1990–2021 [PDF]

Metabolism: Clinical and Experimental
Common metabolic diseases, such as type 2 diabetes mellitus (T2DM), hypertension, obesity, hypercholesterolemia, and metabolic dysfunction-associated steatotic liver disease (MASLD), have become a global health burden in the last three decades. The Global Burden of Disease, Injuries, and Risk Factors Study (GBD) data enables the first insights into the
Alice Kong, Yu-Jun Wong, Said A Al-Busafi   +2 more
exaly   +8 more sources